Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Frontera London

- PMLiVE

Novartis reveals positive efficacy data for Xolair follow-up

Next-generation treatment is more effective than current therapy

- PMLiVE

Roudie Shafie joins OVID Health’s senior team as director

Shafie's previous experience includes roles at the ABPI and Pfizer UK

- PMLiVE

Health research crisis in the NHS is putting patient care at risk

New report highlights importance of research in the health service

- PMLiVE

Almirall eyes $62m takeover of multicytokine specialist Bioniz

Gains clinical-stage drug for cutaneous T-cell lymphoma

- PMLiVE

Northsea Therapeutics raises $40m to develop fish oil NASH drug

Looking for mid-stage trial success in field littered with failures

OPEN Health becomes sponsor of MedComms Networking

New for 2020, OPEN Health is pleased to announce its sponsorship of MedComms Networking

OPEN Health

- PMLiVE

Apellis jumps as pegcetacoplan tops Alexion’s Soliris in PNH trial

Shares shot up more than 50% in wake of announcement

- PMLiVE

New hires at FibroGen, Saniona and Turbine

The latest movers in pharma

- PMLiVE

imc group bolsters HR & talent division

Anushka Bakshi and Parissa Kamal join the imc team

- PMLiVE

Galen completes acquisition of healthcare company POA Pharma

Takeover expands Galen's global reach and product portfolio

- PMLiVE

Novartis picks up inclisiran after completion of MedCo acquisition

If approved could become blockbuster cholesterol treatment

- PMLiVE

Keytruda doesn’t extend survival in small cell lung cancer

Unlikely to extend use into the first-line setting

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links